Accueil   Diary - News   All news GeNeuro to Present at 3rd 2019 HERVs & Disease International Workshop on Human Endogenous Retroviruses (HERVs) and Diseases

GeNeuro to Present at 3rd 2019 HERVs & Disease International Workshop on Human Endogenous Retroviruses (HERVs) and Diseases

 

  • A must-attend and rapidly growing event with experts around the world: 36 speakers from 10 countries
     
  • In-depth scientific review of the role played by the HERVs in a broad range of diseases including multiple sclerosis, amyotrophic lateral sclerosis and cancer
     
  • Focus on positive Phase 2 clinical trial results with GeNeuro’s temelimab through presentation by PD Dr. David Kremer, Heinrich-Heine-University of Düsseldorf, Germany

 

Geneva, Switzerland, October 31, 2019 –  GeNeuro (Euronext Paris: CH0308403085 - GNRO), a biopharmaceutical company developing new treatments for neurological and autoimmune diseases, such as multiple sclerosis (MS) and type-1 diabetes, announced that the company will present at and sponsor the 3rd HERVs & Disease International Workshop on Human Endogenous Retroviruses and Diseases, to be held November 5-6, 2019, in Lyon, France.

 

Read the press release

By continuing your navigation on our site, you accept the use of cookies and the collection of your data and personal information by Lyonbiopôle, for the purposes of measuring the traffic on the website, to provide statistics and to offer you adapted content to your centers of interest. To exercise your rights of access, rectification, opposition, deletion and portability, in accordance with the General Data Protection Regulation (EU 2016/679), you are informed that you can send your request to dpo@lyonbiopole.com. More details are available by clicking here I agree